J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published online Nov. 27 in Nutrients.

SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...

Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the ...

Researchers have found in a new real-world study that dupilumab was an effective and safe therapeutic option for head and ...

A review indicates that probiotic, prebiotic, and synbiotic supplements could be beneficial for skin health, especially for ...

Avène is a French pharmacy brand renowned for its popular range of products, including this nourishing cream. It is designed ...

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.

Cerapro® is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE ...

Cerapro is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE Mark)Product launch targeted for 2026 in six European ...